Arnuity Ellipta Drug Interactions
Currently displaying a list of 112 drugs known to interact with Arnuity Ellipta (fluticasone).
- 37 major drug interactions
- 59 moderate drug interactions
- 16 minor drug interactions
Medications known to interact with Arnuity Ellipta
Note: Showing generic names only.
A
- abametapir topical
- adagrasib
- albuterol
- amprenavir
- apalutamide
- aprepitant
- arformoterol
- asciminib
- atazanavir
- axicabtagene ciloleucel
B
C
- ceritinib
- chloramphenicol
- ciltacabtagene autoleucel
- ciprofloxacin
- cladribine
- clarithromycin
- cobicistat
- conivaptan
- crizotinib
D
E
F
- fedratinib
- fenfluramine
- fexinidazole
- fluconazole
- formoterol
- fosamprenavir
- fosaprepitant
- fostamatinib
I
- idecabtagene vicleucel
- idelalisib
- imatinib
- indacaterol
- indinavir
- indium oxyquinoline in-111
- insulin inhalation, rapid acting
- isavuconazonium
- isoetharine
- isoproterenol
- itraconazole
K
L
- lapatinib
- larotrectinib
- lefamulin
- lenacapavir
- letermovir
- levalbuterol
- levoketoconazole
- lisocabtagene maraleucel
- lonafarnib
- lonapegsomatropin
- lorlatinib
M
N
O
P
R
S
T
V
Arnuity Ellipta disease interactions
There are 6 disease interactions with Arnuity Ellipta (fluticasone) which include:
- hepatic impairment
- infections
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- hyperadrenocorticism
More about Arnuity Ellipta (fluticasone)
- Arnuity Ellipta consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (16)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: inhaled corticosteroids
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.